Kevin G Moder
Overview
Explore the profile of Kevin G Moder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pham M, Orsolini G, Crowson C, Snyder M, Pruthi R, Moder K
Thromb Haemost
. 2022 Jun;
122(11):1948-1950.
PMID: 35697257
No abstract available.
2.
Dabit J, Hocaoglu M, Moder K, Barkmeier A, Smith W, OByrne T, et al.
Rheumatology (Oxford)
. 2021 Nov;
61(8):3172-3179.
PMID: 34788400
Objectives: We aimed to estimate the risk of HCQ retinopathy and its risk factors among incident users in the community. Methods: Using the Rochester Epidemiology Project, a record-linkage system, a...
3.
Crowson C, Moder K, Snyder M
J Appl Lab Med
. 2021 Feb;
1(3):320-321.
PMID: 33626848
No abstract available.
4.
Utility of Antinuclear Antibody Screening by Various Methods in a Clinical Laboratory Patient Cohort
Deng X, Peters B, Ettore M, Ashworth J, Brunelle L, Crowson C, et al.
J Appl Lab Med
. 2021 Feb;
1(1):36-46.
PMID: 33626797
Background: Antinuclear antibody (ANA)5 testing is routinely performed during evaluation of patients with a suspected connective tissue disease (CTD), yet the question of which method is most appropriate remains controversial....
5.
Duarte-Garcia A, Pham M, Crowson C, Amin S, Moder K, Pruthi R, et al.
Arthritis Rheumatol
. 2019 Apr;
71(9):1545-1552.
PMID: 30957430
Objective: To estimate the annual incidence and prevalence of and frequency of mortality associated with antiphospholipid syndrome (APS). Methods: An inception cohort of patients with incident APS in 2000-2015 from...
6.
Guerra H, Pittock S, Moder K, Fryer J, Gadoth A, Flanagan E
Mayo Clin Proc
. 2018 Apr;
93(9):1299-1304.
PMID: 29655487
Antiphospholipid (aPL) antibodies have historically been postulated to cause a poorly understood inflammatory myelitis. Neuromyelitis optica spectrum disorder (NMOSD) causes an inflammatory longitudinally extensive transverse myelitis (LETM). In 2004, aquaporin-4...
7.
Ungprasert P, Crowson C, Chowdhary V, Ernste F, Moder K, Matteson E
Arthritis Care Res (Hoboken)
. 2016 Mar;
68(12):1843-1848.
PMID: 26946215
Objective: To characterize the epidemiology of mixed connective tissue disease (MCTD) from 1983 to 2014. Methods: An inception cohort of patients with incident MCTD in 1985-2014 in Olmsted County, Minnesota...
8.
Guerra H, Pittock S, Moder K, Froehling D, Flanagan E
J Neurol Sci
. 2016 Jan;
361:204-5.
PMID: 26810544
No abstract available.
9.
Jain S, Thongprayoon C, Espinosa R, Hayes S, Klarich K, Cooper L, et al.
Am J Cardiol
. 2015 Aug;
116(8):1277-9.
PMID: 26279106
Recurrent pericarditis is a debilitating condition that can be recalcitrant to conventional therapy with nonsteroidal anti-inflammatory agents, colchicine, and glucocorticoids. The aim of this study was to evaluate the therapeutic...
10.
Schaefer J, McBane R, Black D, Williams L, Moder K, Wysokinski W
Thromb Haemost
. 2014 Aug;
112(5):947-50.
PMID: 25118790
Direct oral factor inhibitors (DOFIs) are an attractive alternative to vitamin K antagonists (VKA) for the treatment of patients with antiphospholipid syndrome (APS). In the absence of prospective, randomised trial...